Extensive experience in basic, translational, and clinical research in COPD, pulmonary fibrosis, influenza viral infections, bacterial pneumonia, ARDS, and asthma with > 140 peer-reviewed publications. Editorial board member for 4 journals, and reviewer on multiple NIH study sections including Special Emphasis Panels, Lung Injury, Repair and Regeneration, and SBIR-STTR Respiratory Sciences panel. Extensive collaborations with pharmaceutical and biotechnology companies. Mentored > 60 MD, PhD, and pre-med trainees in biomedical research. Led several Phase 2-3 large multi-national Phase 2-3 clinical trials testing the safety, tolerability and efficacy of CFTR modulators in pediatric and adult subjects and successful submissions for market authorization to FDA, CHMP, Health Canada, TGA, Swiss Medic, and other regulatory authorities. Experience in cross-functional team-work and Good Clinical Practice.